Key Takeaways
- SpaceX shares gained approximately 1% during Monday’s premarket session following implementation of Nasdaq-100 index rebalancing.
- The company’s weighting within the index jumped to 2.82% from approximately 1.28%.
- According to TipRanks analysis, this adjustment may generate between $15.5 billion and $22 billion in passive institutional purchases.
- NASA recently awarded SpaceX a $946 million contract extension for three additional astronaut transport missions.
- Market participants continue monitoring the company’s upcoming Starship test flight schedule.
SpaceX (SPCX) shares advanced approximately 1% during Monday’s premarket session following implementation of a significant Nasdaq-100 index rebalancing. The stock traded near $153, up from Friday’s closing price of $152.71.
Space Exploration Technologies Corp., SPCX
The primary driver behind this movement is the substantial increase in SpaceX’s representation within the Nasdaq-100 index. According to Bloomberg’s reporting, the company’s weighting has expanded to 2.82% from its prior level of approximately 1.28%.
This expansion requires index-tracking funds to substantially increase their positions in SpaceX shares. Financial analytics firm TipRanks projects this rebalancing could generate passive buying activity ranging from $15.5 billion to $22 billion.
The aerospace manufacturer joined the index last July following its initial public offering. Its initial weighting was limited because Nasdaq calculates exposure partially based on free floatāthe portion of shares readily accessible to public market participants.
Index Rebalancing Boosts SpaceX’s Market Presence
Additional SpaceX shares entered public circulation after post-IPO lockup periods expired. This development enabled the company’s index representation to align more closely with its overall market capitalization.
The increase from 1.28% to 2.82% represents more than a doubling of SpaceX’s Nasdaq-100 footprint. The updated weighting became effective on Monday.
Passive index funds operate independently of fundamental analysis regarding earnings projections or valuation metrics. Instead, they modify portfolio allocations to mirror adjustments implemented by their benchmark indices.
This mechanism generates systematic buying pressure when a constituent company’s weighting expands. The precise volume of purchases may fluctuate based on fund capital flows, replication strategies, and the timing of portfolio manager execution.
SpaceX shares have recently recovered above their $150 IPO debut price. However, they remain trading over 10% below their early July levels, as noted by Barron’s reporting.
Recent NASA Award Provides Additional Positive Development
The index adjustment follows a newly announced $946 million NASA contract disclosed on September 18. The space agency added three SpaceX astronaut transport missions under its Commercial Crew Transportation Capability program.
These missionsādesignated Crew-15, Crew-16, and Crew-17āhave target readiness dates spanning 2027 and 2028. This award increases SpaceX’s total contract value within the program to $5.92 billion.
NASA outlined that the contract encompasses ground operations, launch services, orbital support, return procedures, recovery operations, cargo delivery, and emergency crew return capabilities. The agreement extends through 2030.
Additionally, SpaceX secured another NASA contract last week for launching the StarBurst scientific satellite. This mission is scheduled for no earlier than 2028 utilizing a Falcon 9 rocket.
Market observers are also focusing on forthcoming Starship test campaigns. The company’s developmental milestones represent another near-term consideration beyond the index rebalancing.
For Monday’s trading session, the confirmed catalyst remains the index modification. SpaceX’s Nasdaq-100 weighting now stands at 2.82%, representing more than double its earlier allocation of roughly 1.28%.





